You are here: Home » Reuters » News
Business Standard

'Pharma Bro' Shkreli gets 7 years for defrauding investors

Reuters  |  NEW YORK 

NEW YORK (Reuters) - Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was accused and found guilty of defrauding investors, was sentenced to 7 years on Friday. Shkreli, 34, was sentenced by U.S. District Judge Kiyo Matsumoto in Brooklyn federal court. (Reporting By Brendan Pierson in New York; Editing by Meredith Mazzilli)(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, March 10 2018. 00:34 IST